» Articles » PMID: 24144181

The Campylobacter Jejuni CiaD Effector Protein Activates MAP Kinase Signaling Pathways and is Required for the Development of Disease

Overview
Publisher Biomed Central
Date 2013 Oct 23
PMID 24144181
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Enteric pathogens utilize a distinct set of proteins to modulate host cell signaling events that promote host cell invasion, induction of the inflammatory response, and intracellular survival. Human infection with Campylobacter jejuni, the causative agent of campylobacteriosis, is characterized by diarrhea containing blood and leukocytes. The clinical presentation of acute disease, which is consistent with cellular invasion, requires the delivery of the Campylobacter invasion antigens (Cia) to the cytosol of host cells via a flagellar Type III Secretion System (T3SS). We identified a novel T3SS effector protein, which we termed CiaD that is exported from the C. jejuni flagellum and delivered to the cytosol of host cells.

Results: We show that the host cell kinases p38 and Erk 1/2 are activated by CiaD, resulting in the secretion of interleukin-8 (IL-8) from host cells. Additional experiments revealed that CiaD-mediated activation of p38 and Erk 1/2 are required for maximal invasion of host cells by C. jejuni. CiaD contributes to disease, as evidenced by infection of IL-10 knockout mice. Noteworthy is that CiaD contains a Mitogen-activated protein (MAP) kinase-docking site that is found within effector proteins produced by other enteric pathogens. These findings indicate that C. jejuni activates the MAP kinase signaling pathways Erk 1/2 and p38 to promote cellular invasion and the release of the IL-8 pro-inflammatory chemokine.

Conclusions: The identification of a novel T3SS effector protein from C. jejuni significantly expands the knowledge of virulence proteins associated with C. jejuni pathogenesis and provides greater insight into the mechanism utilized by C. jejuni to invade host cells.

Citing Articles

/ Infection: Is It Still a Concern?.

Veronese P, Dodi I Microorganisms. 2025; 12(12.

PMID: 39770871 PMC: 11728820. DOI: 10.3390/microorganisms12122669.


Pathogenicity and virulence of : What do we really know?.

Omole Z, Dorrell N, Elmi A, Nasher F, Gundogdu O, Wren B Virulence. 2024; 15(1):2436060.

PMID: 39648291 PMC: 11633169. DOI: 10.1080/21505594.2024.2436060.


Campylobacter jejuni virulence factors: update on emerging issues and trends.

Tikhomirova A, McNabb E, Petterlin L, Bellamy G, Lin K, Santoso C J Biomed Sci. 2024; 31(1):45.

PMID: 38693534 PMC: 11064354. DOI: 10.1186/s12929-024-01033-6.


Gut metabolite L-lactate supports population expansion during acute infection.

Sinha R, LeVeque R, Callahan S, Chatterjee S, Stopnisek N, Kuipel M Proc Natl Acad Sci U S A. 2024; 121(2):e2316540120.

PMID: 38170751 PMC: 10786315. DOI: 10.1073/pnas.2316540120.


Campylobacter jejuni: targeting host cells, adhesion, invasion, and survival.

Kemper L, Hensel A Appl Microbiol Biotechnol. 2023; 107(9):2725-2754.

PMID: 36941439 PMC: 10027602. DOI: 10.1007/s00253-023-12456-w.


References
1.
Aguilar J, Lobaina Y, Muzio V, Garcia D, Penton E, Iglesias E . Development of a nasal vaccine for chronic hepatitis B infection that uses the ability of hepatitis B core antigen to stimulate a strong Th1 response against hepatitis B surface antigen. Immunol Cell Biol. 2004; 82(5):539-46. DOI: 10.1111/j.0818-9641.2004.01278.x. View

2.
Jin S, Song Y, Emili A, Sherman P, Chan V . JlpA of Campylobacter jejuni interacts with surface-exposed heat shock protein 90alpha and triggers signalling pathways leading to the activation of NF-kappaB and p38 MAP kinase in epithelial cells. Cell Microbiol. 2003; 5(3):165-74. DOI: 10.1046/j.1462-5822.2003.00265.x. View

3.
Schwerer B . Antibodies against gangliosides: a link between preceding infection and immunopathogenesis of Guillain-Barré syndrome. Microbes Infect. 2002; 4(3):373-84. DOI: 10.1016/s1286-4579(02)01550-2. View

4.
Zurawski D, Mumy K, Faherty C, McCormick B, Maurelli A . Shigella flexneri type III secretion system effectors OspB and OspF target the nucleus to downregulate the host inflammatory response via interactions with retinoblastoma protein. Mol Microbiol. 2008; 71(2):350-68. PMC: 2783611. DOI: 10.1111/j.1365-2958.2008.06524.x. View

5.
Hickey T, McVeigh A, Scott D, Michielutti R, Bixby A, Carroll S . Campylobacter jejuni cytolethal distending toxin mediates release of interleukin-8 from intestinal epithelial cells. Infect Immun. 2000; 68(12):6535-41. PMC: 97747. DOI: 10.1128/IAI.68.12.6535-6541.2000. View